Evidence map›Paper›PMID 35424290›Full record

ArticleRSC advances2021

Interaction analyses of SARS-CoV-2 spike protein based on fragment molecular orbital calculations.

Kazuki Akisawa, Ryo Hatada, Koji Okuwaki, Yuji Mochizuki, Kaori Fukuzawa, Yuto Komeiji, Shigenori Tanaka

Abstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Advancing Medicinal Chemistry Through FMO: Sygnature's Platform.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  3. Article
  4. Structure- and Interaction-Based Design of Anti-SARS-CoV-2 Aptamers.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Article
  5. Article
  6. Fragme∩t: An Open-Source Framework for Multiscale Quantum Chemistry Based on Fragmentation.Wiley interdisciplinary reviews. Computational molecular science
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kazuki AkisawaDepartment of Chemistry and Research Center for Smart Molecules, Faculty of Science, Rikkyo University 3-34-1 Nishi-ikebukuro Toshima-ku Tokyo 171-8501 Japan fullmoon@rikkyo.ac.jp.
Ryo HatadaDepartment of Chemistry and Research Center for Smart Molecules, Faculty of Science, Rikkyo University 3-34-1 Nishi-ikebukuro Toshima-ku Tokyo 171-8501 Japan fullmoon@rikkyo.ac.jp.
Koji OkuwakiDepartment of Chemistry and Research Center for Smart Molecules, Faculty of Science, Rikkyo University 3-34-1 Nishi-ikebukuro Toshima-ku Tokyo 171-8501 Japan fullmoon@rikkyo.ac.jp.ORCID https://orcid.org/0000-0002-4510-5717
Yuji MochizukiDepartment of Chemistry and Research Center for Smart Molecules, Faculty of Science, Rikkyo University 3-34-1 Nishi-ikebukuro Toshima-ku Tokyo 171-8501 Japan fullmoon@rikkyo.ac.jp.ORCID https://orcid.org/0000-0002-7310-5183
Kaori FukuzawaInstitute of Industrial Science, The University of Tokyo 4-6-1 Komaba Meguro-ku Tokyo 153-8505 Japan.ORCID https://orcid.org/0000-0001-5357-8250
Yuto KomeijiHealth and Medical Research Institute, AIST Tsukuba Central 6 Tsukuba Ibaraki 305-8566 Japan.ORCID https://orcid.org/0000-0002-9708-6175
Shigenori TanakaGraduate School of System Informatics, Department of Computational Science, Kobe University 1-1 Rokkodai, Nada-ku Kobe 657-8501 Japan.ORCID https://orcid.org/0000-0002-6659-2788

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At the stage of SARS-CoV-2 infection in human cells, the spike protein consisting of three chains, A, B, and C, with a total of 3300 residues plays a key role, and thus its structural properties and the binding nature of receptor proteins to host human cells or neutralizing antibodies has attracted considerable interest. Here, we report on interaction analyses of the spike protein in both closed (PDB-ID: 6VXX) and open (6VYB) structures, based on large-scale fragment molecular orbital (FMO) calculations at the level of up to the fourth-order Møller-Plesset perturbation with singles, doubles, and quadruples (MP4(SDQ)). Inter-chain interaction energies were evaluated for both structures, and a mutual comparison indicated considerable losses of stabilization energies in the open structure, especially in the receptor binding domain (RBD) of chain-B. The role of charged residues in inter-chain interactions was illuminated as well. By two separate calculations for the RBD complexes with angiotensin-converting enzyme 2 (ACE2) (6M0J) and B38 Fab antibody (7BZ5), it was found that the binding with ACE2 or antibody partially compensated for this stabilization loss of RBD.

Identifiers

PMID35424290
PMCPMC8694004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.